In reply to the Letter to Editor regarding “Isavuconazole Prophylaxis and Treatment in Pediatric HSCT Recipients: Pharmacokinetics, Safety, and Efficacy”
In reply to the Letter to Editor regarding “Isavuconazole Prophylaxis and Treatment in Pediatric HSCT Recipients: Pharmacokinetics, Safety, and Efficacy”. // International Journal of Antimicrobial Agents. – URL: https://www.sciencedirect.com/science/article/pii/S092485792600347X?dgcid=rss_sd_all
In reply to the Letter to Editor regarding “Isavuconazole Prophylaxis and Treatment in Pediatric HSCT Recipients: Pharmacokinetics, Safety, and Efficacy”. International Journal of Antimicrobial Agents. https://www.sciencedirect.com/science/article/pii/S092485792600347X?dgcid=rss_sd_all
“In reply to the Letter to Editor regarding “Isavuconazole Prophylaxis and Treatment in Pediatric HSCT Recipients: Pharmacokinetics, Safety, and Efficacy”.” International Journal of Antimicrobial Agents.
@article{article100378,
title = {In reply to the Letter to Editor regarding “Isavuconazole Prophylaxis and Treatment in Pediatric HSCT Recipients: Pharmacokinetics, Safety, and Efficacy”},
journal = {International Journal of Antimicrobial Agents},
url = {https://www.sciencedirect.com/science/article/pii/S092485792600347X?dgcid=rss_sd_all}
}